Standard Biotools (LAB) EPS (Diluted) Growth (3y) (2022 - 2026)
Standard Biotools (LAB) EPS (Diluted) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 18.07% |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | 31.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.46% |
| Mar 31, 2026 | 54.86% |
| Dec 31, 2025 | -26.05% |
| Sep 30, 2025 | 37.59% |
| Jun 30, 2025 | 61.54% |
| Mar 31, 2025 | 80.77% |
| Sep 30, 2024 | 55.13% |
| Jun 30, 2024 | 47.66% |
| Mar 31, 2024 | 24.27% |
| Dec 31, 2023 | 39.45% |
| Sep 30, 2023 | -47.21% |
| Jun 30, 2023 | -5.68% |
| Mar 31, 2023 | 3.77% |
| Dec 31, 2022 | 130.83% |